STAT August 3, 2022
Angus Chen

TRIALS AND TRUST: This is the second part of a series on health equity and diversity in clinical trials and cancer research.

RICHMOND, Va. — The residents agreed: Nobody like Robert Winn — director of the Virginia Commonwealth University Massey Cancer Center — had ever visited the neighborhood before. This development on the outskirts of Richmond, more parking spots and asphalt than trees and lawn, was “the hood,” after all, they said. “This neighborhood — it’s been so long since we had anybody who even cares to come,” said Glenda Barnhart, a 68-year-old resident. Certainly not anybody from the big hospital.

And now, not only was this doctor with a cheesy grin and a bouncy step before them — he’d...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Provider, Trends
To Promote Health And Health Equity, Include Quality Nutrition Care As Part Of Anti-Obesity Medication Therapy
Is AI Good for Health Equity? California Leaders Weigh In
How Humana is moving beyond awareness during National Minority Health Month
AI-driven prior authorizations: an opportunity for advancing health equity
Accelerating Health Equity Conference Day 2 Highlights

Share This Article